SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-092697
Filing Date
2020-08-10
Accepted
2020-08-10 16:00:30
Documents
53
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2020486-1_10q.htm 10-Q 747626
2 EXHIBIT 31.1 tm2020486d1_ex31-1.htm EX-31.1 9183
3 EXHIBIT 31.2 tm2020486d1_ex31-2.htm EX-31.2 9416
4 EXHIBIT 32.1 tm2020486d1_ex32-1.htm EX-32.1 4487
  Complete submission text file 0001104659-20-092697.txt   4233443

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT catb-20200630.xml EX-101.INS 1087516
6 XBRL TAXONOMY EXTENSION SCHEMA catb-20200630.xsd EX-101.SCH 31579
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE catb-20200630_cal.xml EX-101.CAL 37871
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE catb-20200630_def.xml EX-101.DEF 87581
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE catb-20200630_lab.xml EX-101.LAB 304556
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE catb-20200630_pre.xml EX-101.PRE 202110
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 201089217
SIC: 2834 Pharmaceutical Preparations